Strategic Management To Improve CRT Using Multi-Site Pacing Post Approval Study
Principal Investigator(s)
Email for information
Funded by
GENEVA
Research Start Date
Status
Active
The primary objective of this study is to evaluate the effectiveness of the Boston Scientific’s left ventricular multisite pacing (LV MSP) feature in the Boston Scientific Corporation’s (BSC) resonate family of cardiac resynchronization therapy – defibrillator (CRT-D) devices, and confirm safety in a post approval study when used in accordance with its approved labeling.
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.